StreetInsider.com News Articles

Rubenstein Public Relations Named Agency of Record for OS Therapies

Thu, 08 Oct 2026 09:22:00 -0400

NEW YORK, Oct. 08, 2026 (GLOBE NEWSWIRE) -- Rubenstein Public Relations (RPR), a leading full-service communications firm, announces it has been named the Agency of Record for OS Therapies, Inc. (NYSE American: OSTX), the world leader in gene-edited, Listeria-based cancer immunotherapies.

Recently, OS Therapies announced that it has reached a critical point in achieving entry into the global market with access into the U.K national patient registry and UK Clinical Practice Research Datalink (CPRD) by the U.K. Medicines and Healthcare products Regulatory Agency (MHRA). This comes after OS Therapies

Rubenstein Public Relations Named Agency of Record for OS Therapies

Thu, 08 Oct 2026 09:22:00 -0400

Form 3 OS Therapies Inc For: Sep 29 Filed by: Clem Kerry M

Mon, 05 Oct 2026 16:50:00 -0400

si-local-file:///var/storage/secattach/20261005/27149529.html

Form 3 OS Therapies Inc For: Sep 29 Filed by: Francis Knuettel II

Mon, 05 Oct 2026 16:49:00 -0400

si-local-file:///var/storage/secattach/20261005/27149521.html

Form 8-K OS Therapies Inc For: Sep 29

Mon, 05 Oct 2026 16:38:00 -0400

si-local-file:///var/storage/secattach/20261005/27149362.html

OS Therapies gets MHRA lead role in global OST-HER2 review

Mon, 21 Sep 2026 06:32:55 -0400

OS Therapies, Inc. (NYSE American: OSTX) announced that the U.K.'s Medicines and Healthcare products Regulatory Agency (MHRA) will serve as the lead regulatory agency for early market access coordination for its OST-HER2 therapy under Project Orbis, an FDA initiative that provides a framework for concurrent submission and review of oncology products among international partners.

The therapy targets the prevention or delay of recurrence in fully resected, pulmonary metastatic osteosarcoma. The company said MHRA confirmed it will accept a pending Conditional Marketing Authorisation Application (CMAA) submission expected in the coming weeks.

The FDA has aligned with OS Therapies on the proposed adaptive design

OS Therapies gets MHRA lead role in global OST-HER2 review

Mon, 21 Sep 2026 06:32:55 -0400

The FDA has aligned with OS Therapies on the proposed adaptive design

OS Therapies gets MHRA lead role in global OST-HER2 review

Mon, 21 Sep 2026 06:32:55 -0400

The FDA has aligned with OS Therapies on the proposed adaptive design

Form S-8 OS Therapies Inc

Mon, 21 Sep 2026 06:07:00 -0400

si-local-file:///var/storage/secattach/20260921/27082549.html

Form 8-K OS Therapies Inc For: Sep 10

Thu, 10 Sep 2026 17:28:00 -0400

si-local-file:///var/storage/secattach/20260910/27049515.html

Form 424B7 OS Therapies Inc

Thu, 10 Sep 2026 17:24:00 -0400

si-local-file:///var/storage/secattach/20260910/27049474.html

Form 8-K OS Therapies Inc For: Sep 09

Wed, 09 Sep 2026 16:18:00 -0400

si-local-file:///var/storage/secattach/20260909/27042812.html

Form D OS Therapies Inc

Tue, 25 Aug 2026 16:03:00 -0400

si-local-file:///var/storage/secattach/20260825/26974604.html

Form D OS Therapies Inc

Tue, 25 Aug 2026 16:03:00 -0400

si-local-file:///var/storage/secattach/20260825/26974604.html

Form 8-K OS Therapies Inc For: Aug 21

Fri, 21 Aug 2026 16:51:00 -0400

si-local-file:///var/storage/secattach/20260821/26962088.html

Form 8-K OS Therapies Inc For: Aug 21

Fri, 21 Aug 2026 16:51:00 -0400

si-local-file:///var/storage/secattach/20260821/26962088.html

Form 424B5 OS Therapies Inc

Fri, 21 Aug 2026 16:30:00 -0400

si-local-file:///var/storage/secattach/20260821/26961773.html

Form 424B5 OS Therapies Inc

Fri, 21 Aug 2026 16:30:00 -0400

si-local-file:///var/storage/secattach/20260821/26961773.html

Form 10-Q OS Therapies Inc For: Jun 30

Fri, 14 Aug 2026 17:02:00 -0400

si-local-file:///var/storage/secattach/20260814/26932474.html

Form 10-Q OS Therapies Inc For: Jun 30

Fri, 14 Aug 2026 17:02:00 -0400

si-local-file:///var/storage/secattach/20260814/26932474.html

Form 8-K OS Therapies Inc For: Aug 06

Wed, 12 Aug 2026 16:56:00 -0400

si-local-file:///var/storage/secattach/20260812/26913935.html

Form 8-K OS Therapies Inc For: Aug 06

Wed, 12 Aug 2026 16:56:00 -0400

si-local-file:///var/storage/secattach/20260812/26913935.html

Form 8-K OS Therapies Inc For: Jul 31

Thu, 06 Aug 2026 16:13:00 -0400

si-local-file:///var/storage/secattach/20260806/26884142.html

Form 8-K OS Therapies Inc For: Jul 31

Thu, 06 Aug 2026 16:13:00 -0400

si-local-file:///var/storage/secattach/20260806/26884142.html

Form 424B5 OS Therapies Inc

Thu, 06 Aug 2026 16:13:00 -0400

si-local-file:///var/storage/secattach/20260806/26884103.html